120 related articles for article (PubMed ID: 20721491)
1. Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients.
Morais CN; Carvalho Bde M; Melo WG; Melo FL; Lopes EP; Domingues AL; Jucá N; Martins JR; Diniz GT; Montenegro SM
Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):460-6. PubMed ID: 20721491
[TBL] [Abstract][Full Text] [Related]
2. Differentiating cirrhosis and chronic hepatosplenic schistosomiasis using MRI.
Bezerra AS; D'Ippolito G; Caldana RP; Leopoldino DD; Batista GR; Borges DR; Lopes Filho Gde J; Ahmed M
AJR Am J Roentgenol; 2008 Mar; 190(3):W201-7. PubMed ID: 18287413
[TBL] [Abstract][Full Text] [Related]
3. Renal changes in patients with hepatosplenic schistosomiasis.
Andrade ZA; Andrade SG; Sadigursky M
Am J Trop Med Hyg; 1971 Jan; 20(1):77-83. PubMed ID: 5567743
[No Abstract] [Full Text] [Related]
4. Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonica.
Hou XY; Ellis MK; McManus DP; Wang YY; Li SD; Williams GM; Li YS
Int J Parasitol; 2011 Mar; 41(3-4):325-32. PubMed ID: 21145322
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cytokines IL-10 and IL-13 as mediators in the progression of Symmers fibrosis in patients with hepatosplenic schistosomiasis mansoni.
Brandt CT; Rino M; Pitta MG; Muniz JS; Silveira Dde O; Castro CM
Rev Col Bras Cir; 2010 Oct; 37(5):333-7. PubMed ID: 21180998
[TBL] [Abstract][Full Text] [Related]
6. Serum beta-2-microglobulin in intestinal and hepatosplenic bilharziasis.
Nasser HE; Amer MS; Taha MA; Shawkat A; Abo-Elmaged L; El Missiry AG; Khalil I; Schoukry NA; Abdel Mohsen A; Soliman H
J Egypt Soc Parasitol; 1983 Dec; 13(2):423-7. PubMed ID: 6363570
[No Abstract] [Full Text] [Related]
7. Ultrasonography of the liver and spleen in Brazilian patients with hepatosplenic schistosomiasis and cirrhosis.
Pereira LM; Domingues AL; Spinelli V; McFarlane IG
Trans R Soc Trop Med Hyg; 1998; 92(6):639-42. PubMed ID: 10326109
[TBL] [Abstract][Full Text] [Related]
8. [Hepatosplenic schistosomiasis mansoni: a tragic disease].
de Oliveira-e-Silva A; D'Albuquerque LA
Arq Gastroenterol; 2003; 40(4):201-2. PubMed ID: 15264039
[No Abstract] [Full Text] [Related]
9. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis.
Kamal SM; Turner B; He Q; Rasenack J; Bianchi L; Al Tawil A; Nooman A; Massoud M; Koziel MJ; Afdhal NH
Hepatology; 2006 Apr; 43(4):771-9. PubMed ID: 16557547
[TBL] [Abstract][Full Text] [Related]
10. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
11. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
12. [Functional and immunologic evaluation of prothrombin in the hepatosplenic form of schistosomiasis and hepatic cirrhosis].
Manoukian N; Borges DR
Rev Paul Med; 1983; 101(5):182-5. PubMed ID: 6672979
[No Abstract] [Full Text] [Related]
13. ABO blood groups in hepato-splenic schistosomiasis.
El Masri SH; Sharfi AR
J Trop Med Hyg; 1982 Oct; 85(5):223-4. PubMed ID: 6983589
[No Abstract] [Full Text] [Related]
14. Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.
Sinkala E; Zyambo K; Besa E; Kaonga P; Nsokolo B; Kayamba V; Vinikoor M; Zulu R; Bwalya M; Foster GR; Kelly P
Am J Trop Med Hyg; 2018 Apr; 98(4):1152-1158. PubMed ID: 29436337
[TBL] [Abstract][Full Text] [Related]
15. [Serum globulin levels and intensity of hepatic fibrosis in patients with mansonic schistosomiasis].
Correia HS; Domingues AL; Lopes EP; Morais CN; Sarteschi C; Moura IM
Arq Gastroenterol; 2009; 46(3):194-8. PubMed ID: 19918685
[TBL] [Abstract][Full Text] [Related]
16. Increased Hepatic Arterial Blood Flow Measured by Hepatic Perfusion Index in Hepatosplenic Schistosomiasis: New Concepts for an Old Disease.
de Carvalho BT; Coutinho Domingues AL; de Almeida Lopes EP; Brandão SC
Dig Dis Sci; 2016 Jul; 61(7):2118-26. PubMed ID: 26921079
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive fibrosis tests are correlated with necroinflammatory actvity of liver in patients with chronic hepatitis B.
Ozyalvacli G; Kucukbayrak A; Kurt M; Gurel K; Gunes O; Ustun C; Akdeniz H
Clin Ter; 2014; 165(3):e199-204. PubMed ID: 24999574
[TBL] [Abstract][Full Text] [Related]
19. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
20. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
